Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Guideline for the treatment of bronchial asthma in children and adolescents].

Literature DB >> 18239993

[Guideline for the treatment of bronchial asthma in children and adolescents].

Josef Riedler¹, Ernst Eber, Thomas Frischer, Manfred Götz, Elisabeth Horak, Maximilian Zach.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2008 PMID： 18239993 DOI： 10.1007/s00508-007-0924-y

Source DB: PubMed Journal: Wien Klin Wochenschr ISSN： 0043-5325 Impact factor: 1.704

× No keyword cloud information.

30 in total

1. [Consensus guidelines for drug therapy of bronchial asthma in children and adolescents. Austrian Society of Pediatrics and Adolescent Medicine and Austrian Society for Lung Diseases and Tuberculosis].

Authors: T Frischer; E Eber; I Eichler; E Horak; J Riedler; M Götz; M Zach
Journal: Wien Klin Wochenschr Date: 1999-11-12 Impact factor: 1.704

2. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study.

Authors: Maria Fritsch; Sabine Uxa; Friedrich Horak; Bettina Putschoegl; Eleonora Dehlink; Zsolt Szepfalusi; Thomas Frischer
Journal: Pediatr Pulmonol Date: 2006-09

3. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

Authors: Nhân Pham-Thi; Pierre Scheinmann; Riad Fadel; Anne Combebias; Claude Andre
Journal: Pediatr Allergy Immunol Date: 2007-02 Impact factor: 6.377

4. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

Authors: Angela Zacharasiewicz; Nicola Wilson; Christiane Lex; Edward M Erin; Albert M Li; Trevor Hansel; Mohammed Khan; Andrew Bush
Journal: Am J Respir Crit Care Med Date: 2005-02-11 Impact factor: 21.405

5. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

Authors: Stanley J Szefler; Brenda R Phillips; Fernando D Martinez; Vernon M Chinchilli; Robert F Lemanske; Robert C Strunk; Robert S Zeiger; Gary Larsen; Joseph D Spahn; Leonard B Bacharier; Gordon R Bloomberg; Theresa W Guilbert; Gregory Heldt; Wayne J Morgan; Mark H Moss; Christine A Sorkness; Lynn M Taussig
Journal: J Allergy Clin Immunol Date: 2005-02 Impact factor: 10.793

[Guideline for the treatment of bronchial asthma in children and adolescents].

1. [Consensus guidelines for drug therapy of bronchial asthma in children and adolescents. Austrian Society of Pediatrics and Adolescent Medicine and Austrian Society for Lung Diseases and Tuberculosis].

2. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study.

3. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

4. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

5. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

6. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.

7. Asthma guideline use by pediatricians in private practices and asthma morbidity.

8. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.

Review 9. Sublingual immunotherapy for allergic rhinitis.

Review 10. Breaking new ground: challenging existing asthma guidelines.

1. [Respiratory emergencies in childhood and adolescence].